Hermon Ringworm Treatment Kit Miconazole Nitrate 2% and Clotrimazole 1% Kit — NDC 85398-027-01 (Billing 85398-0027-01)
This is a package of Hermon Ringworm Treatment Kit Miconazole Nitrate 2% and Clotrimazole 1% Kit from Beautivity LLC, marketed since Mar 2026 and currently FDA-listed. It is this product's only package size.
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 251267
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Azole Antifungal class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
This is an over-the-counter topical kit containing two antifungal medications: miconazole nitrate 2% and clotrimazole 1%. Both ingredients are commonly used to treat fungal skin infections, including ringworm, by slowing or stopping the growth of fungi on the skin surface. The kit format allows users to apply the products as directed for managing ringworm and related fungal conditions. This product is marketed under FDA's over-the-counter monograph rules for antifungal treatments.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 3, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 85398-0027-01 You're viewing this Main listing | 1 KIT in 1 CARTON * 116 g in 1 BOTTLE, PLASTIC * 100 g in 1 CARTON | 2026-03-05 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Hermon Ringworm Treatment Kitthis 85398-0027-01 | Beautivity | 1 kit | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Sep 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Wash affected area and dry thoroughly Apply a thin layer over affected area twice daily (morning and night) or as directed by a doctor Supervise children in the use of this product For athlete's foot, pay special attention to spaces between the toes, wear well-fitting. ventilated shoes and change shoesand socks at least once a day For athlete's foot and ringworm use daily for 4 weeks, for jock itch use daily for 2 weeks If conditions persist longer, ask a doctor This product is not effective on the scalp or nails.
⏱️ Dosage and Administration ▾
Cures most athlete's feet, jock itch, and ringworm. Relieves itching, burning, cracking, scaling and discomfort which accompany these conditions.
⚠️ Warnings ▾
For external use only. children under 2 years of age unless directed by a doctor. Avoide contact with eyes. If contact occurs, rinse thoroughly with water. Stop use and ask doctor if irritation occurs or if there is noimprovement within 2 weeks. If swallowed, get medical helpor contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Cream: Miconazole Nitrate 2% Soap Bar: Clotrimazole 1%
🧪 Inactive Ingredients ▾
Cream: Water, Dimethicone, Mineral Oil. Petrolatum, Glycerin, Glyceryl Monostearate, Menthol Zanthoxylum Bungeanum Fruit Extract, Viola Yedoensis Extract Euphorbia Hirta Extract, Murraya Paniculata Leaf Extract, Sophora Flavescens Root Extract, Cnidium Monnieri Fruit Extract, Smilax Glabra Root Extract, Ophiopogon Japonicus Root Extract, Phellodendron Amurense Bark Extract, Gleditsia Sinensis Thorn Extract, Stemona Sessilifolia Root Extract, Borneol, Chlorhexidine Acetate,Dictamnus Dasycarpus Root Bark Extract, Kochia Scoparia Fruit Extract.
Soap Bar: Sorbitol, Sucrose, Stearic Acid, Propylene Glycol, Sodium Palmate, Water, Glycerin, Butyrospermum Parki (Shea) Butter, Lauric Acid, Sodium Hydroxide, Cocos Nucifera (Coconut) Oil, Fragrance, Aloe Barbadensis Leaf Juice, Melaleuca Alternifolia (Tea Tree) Leaf Oil
🎯 Purpose ▾
Antifungal
📄 Do Not Use ▾
children under 2 years of age unless directed by a doctor.
📄 Ask a Doctor Before Use If ▾
Stop use and ask doctor if irritation occurs or if there is noimprovement within 2 weeks.
📄 When Using This Product ▾
Avoide contact with eyes. If contact occurs, rinse thoroughly with water.
📄 Keep Out of Reach of Children ▾
If swallowed, get medical helpor contact a Poison Control Center right away.
📄 Other Information ▾
Store at 20°C to 25° C (68°F to 77° F). Close the cap tightly after use.
📄 Questions or Comments ▾
Questions? visit us at www.hermonhealth.com Contact us [email protected] Tel: +1 5734764179
📄 Package Label / Principal Display Panel ▾
package
About this NDC listing & data coverage
Kit / multi-component package
This NDC identifies a kit — a package containing more than one component. Structured data (pricing, ingredients, equivalents) is often reported per component rather than for the kit NDC itself, which can make this page look thinner than the components' own pages.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |